Sedana Medical says FDA accepts NDA for isoflurane ICU sedation system for review
Reuters2026/08/19 05:32Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- Sedana Medical NDA for isoflurane via its ACD Delivery System accepted for FDA review in U.S. mechanically ventilated adult ICU sedation.
- FDA to set a PDUFA target action date within the next weeks.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sedana Medical AB published the original content used to generate this news brief on August 19, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Kapsch TrafficCom announces annual general meeting
Reuters•2026/08/19 10:14
SCP Standard Capital Partners posts H1 FY26 EBIT loss of EUR 2.41 million; revenue EUR 469,000
Reuters•2026/08/19 10:10
2-Yr Benchmark Govt Yields - Germany vs Other Nations
Dow Jones•2026/08/19 10:10
